Global Enteric Disease Testing Market 2014-2018

TechNavio's analysts forecast the Global Enteric Disease Testing market to grow at a CAGR of 2.83 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of enteric diseases. The Global Enteric Disease Testing market has also been witnessing the emergence of new pathogens causing infections. However, the stringent regulatory approval could pose a challenge to the growth of this market.
TechNavio's report, the Global Enteric Disease Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Enteric Disease Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space are Alere Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Cepheid Inc. and DiaSorin S.p.A.
Other vendors mentioned in the report are Affymetrix Inc., Beckton, Dickenson and Co., Biomerica Inc., Coris BioConcept, Danaher Corp., Meridian Bioscience Inc., Quest Diagnostics Inc., R-Biopharm AG, and Trinity Biotech PLC.
Key questions answered in this report:
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Type of Diseases
07.1 Global Bacterial Enteric Disease Testing Market
07.1.1 Market Size and Forecast
07.2 Global Parasitic Enteric Diseases Testing Market
07.2.1 Market Size and Forecast
07.3 Global Viral Enteric Diseases Testing Market
07.3.1 Market Size and Forecast
08. Types of Clinical Diagnostic Testing
09. Geographical Segmentation
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.2 Market Share Analysis 2013
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Alere Inc.
18.1.1 Business Overview
18.1.2 Business Segmentation
18.1.3 Key Information
18.1.4 SWOT Analysis
18.2 bioMerieux SA
18.2.1 Key Information
18.2.2 SWOT Analysis
18.3 Bio-Rad Laboratories Inc.
18.3.1 Business Overview
18.3.2 Business Segmentation
18.3.3 Key Information
18.3.4 SWOT Analysis
18.4 Cepheid Inc.
18.4.1 Business Overview
18.4.2 Key Information
18.4.3 SWOT Analysis
18.5 DiaSorin S.p.A.
18.5.1 Business Overview
18.5.2 Key Information
18.5.3 SWOT Analysis
19. Other Reports in this Series


List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Enteric Diseases Market 2013-2018 (US$ billion)
Exhibit 3: Global Enteric Disease Testing Market Segmentation by Type of Diseases
Exhibit 4: Global Market Segmentation Based on Type of Diseases 2013
Exhibit 5: Bacterial Enteric Disease Testing Market 2013-2018(US$ billion)
Exhibit 6: Parasitic Enteric Disease Testing Market 2013-2018(US$ billion)
Exhibit 7: Viral Enteric Disease Testing Market 2013-2018(US$ billion)
Exhibit 8: Comparison of YOY Growth Rate by Market Segments for Global Enteric Disease Testing Market 2013-2018
Exhibit 9: Global Enteric Disease Testing Market Segmentation 2013-2018 (by Percentage)
Exhibit 10: Global Enteric Disease Testing Market by Geographical Segmentation 2013
Exhibit 11: Business Segmentation of Alere Inc.
Exhibit 12: Business Segmentation of bioMerieux SA
Exhibit 13: Business Segmentation of Bio-Rad Laboratories Inc.